Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Relypsa Inc (RLYP) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Relypsa Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1416792.
Total stock buying since 2014: $6,725,330.
Total stock sales since 2014: $283,905,589.
Total stock option exercises since 2014: $2,451,300.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2016 | 37,500 | $502,830 | 4,087,188 | $130,704,553 | 0 | $0 |
| 2015 | 500,000 | $6,222,500 | 2,276,819 | $73,928,882 | 269,473 | $1,454,178 |
| 2014 | 0 | $0 | 2,942,266 | $79,272,154 | 223,089 | $997,122 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2016-08 | 500 | $15,960 | 37,510 | $1,198,799 | 0 | $0 |
| 2016-07 | 0 | $0 | 4,043,600 | $129,388,328 | 0 | $0 |
| 2016-06 | 0 | $0 | 6,078 | $117,426 | 0 | $0 |
| 2016-03 | 37,000 | $486,870 | 0 | $0 | 0 | $0 |
| 2015-12 | 0 | $0 | 605,750 | $16,624,254 | 100,750 | $607,960 |
| 2015-10 | 500,000 | $6,222,500 | 0 | $0 | 0 | $0 |
| 2015-09 | 0 | $0 | 646 | $14,832 | 0 | $0 |
| 2015-08 | 0 | $0 | 8,508 | $211,014 | 0 | $0 |
| 2015-07 | 0 | $0 | 30,000 | $1,015,090 | 25,000 | $185,000 |
| 2015-06 | 0 | $0 | 18,329 | $658,283 | 8,555 | $63,307 |
| 2015-05 | 0 | $0 | 1,483,385 | $50,690,340 | 25,834 | $171,102 |
| 2015-04 | 0 | $0 | 5,832 | $206,178 | 5,832 | $23,094 |
| 2015-03 | 0 | $0 | 19,353 | $768,731 | 18,834 | $79,195 |
| 2015-02 | 0 | $0 | 31,182 | $1,173,831 | 10,834 | $52,663 |
| 2015-01 | 0 | $0 | 73,834 | $2,566,329 | 73,834 | $271,857 |
| 2014-12 | 0 | $0 | 611,806 | $18,408,470 | 22,169 | $103,084 |
| 2014-11 | 0 | $0 | 40,834 | $1,000,160 | 40,834 | $188,668 |
| 2014-10 | 0 | $0 | 2,500 | $48,970 | 2,500 | $11,625 |
| 2014-09 | 0 | $0 | 715,707 | $18,537,670 | 9,167 | $44,911 |
| 2014-08 | 0 | $0 | 1,522,252 | $40,096,016 | 99,252 | $451,258 |
| 2014-07 | 0 | $0 | 49,167 | $1,180,868 | 49,167 | $197,576 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-08-17 | Dondero James D (10% Owner) | Buy | 500 | 31.92 | 15,960 |
| 2016-08-16 | Montgomery Monte (Chief Accounting Officer) | Sale | 510 | 31.92 | 16,279 |
| 2016-08-11 | Dondero James D (10% Owner) | Sale | 37,000 | 31.96 | 1,182,520 |
| 2016-07-25 | Isaly Samuel D | Sale | 343,600 | 31.98 | 10,988,328 |
| 2016-07-22 | Isaly Samuel D | Sale | 3,700,000 | 32.00 | 118,400,000 |
| 2016-06-07 | Hillan Kenneth J. | Sale | 1,013 | 19.31 | 19,563 |
| 2016-06-07 | Butler John P. | Sale | 1,013 | 19.32 | 19,570 |
| 2016-06-07 | Torley Helen | Sale | 1,013 | 19.32 | 19,570 |
| 2016-06-07 | Hastings Paul J | Sale | 1,013 | 19.32 | 19,573 |
| 2016-06-07 | Spiegelman Daniel K | Sale | 1,013 | 19.31 | 19,562 |
| 2016-06-07 | Mcgirr David W J | Sale | 1,013 | 19.34 | 19,588 |
| 2016-03-16 | Ball Kristine M (Chief Financial Officer & SVP) | Buy | 7,000 | 12.15 | 85,050 |
| 2016-03-15 | Schuetz Thomas J. | Buy | 30,000 | 13.39 | 401,820 |
| 2015-12-31 | Stahl Wilhelm (SVP, Chief Technology Officer) | Sale | 20,000 | 28.53 | 570,560 |
| 2015-12-31 | Stahl Wilhelm (SVP, Chief Technology Officer) | Option Ex | 20,000 | 3.96 | 79,200 |
| 2015-12-23 | Isaly Samuel D | Sale | 100,000 | 27.16 | 2,716,000 |
| 2015-12-22 | Isaly Samuel D | Sale | 150,000 | 26.70 | 4,005,749 |
| 2015-12-21 | Isaly Samuel D | Sale | 250,000 | 27.95 | 6,986,250 |
| 2015-12-09 | Berman Lance (Chief Medical Officer and SVP) | Sale | 750 | 29.50 | 22,125 |
| 2015-12-09 | Berman Lance (Chief Medical Officer and SVP) | Option Ex | 750 | 7.40 | 5,550 |
| 2015-12-07 | Orwin John A (President & CEO) | Sale | 15,000 | 28.68 | 430,170 |
| 2015-12-07 | Orwin John A (President & CEO) | Option Ex | 10,000 | 7.40 | 74,000 |
| 2015-12-07 | Berman Lance (Chief Medical Officer and SVP) | Sale | 30,000 | 29.78 | 893,400 |
| 2015-12-07 | Berman Lance (Chief Medical Officer and SVP) | Option Ex | 30,000 | 5.11 | 153,210 |
| 2015-12-04 | Orwin John A (President & CEO) | Sale | 20,000 | 25.00 | 500,000 |
| 2015-12-04 | Orwin John A (President & CEO) | Option Ex | 20,000 | 7.40 | 148,000 |
| 2015-12-02 | Orwin John A (President & CEO) | Sale | 20,000 | 25.00 | 500,000 |
| 2015-12-02 | Orwin John A (President & CEO) | Option Ex | 20,000 | 7.40 | 148,000 |
| 2015-10-22 | Isaly Samuel D | Buy | 500,000 | 12.45 | 6,222,500 |
| 2015-09-02 | Ball Kristine M (Chief Financial Officer & SVP) | Sale | 646 | 22.96 | 14,832 |
| 2015-08-17 | Corbett Mary (Senior VP, Human Resources) | Sale | 522 | 24.72 | 12,904 |
| 2015-08-17 | Krasnow Ronald A. (See Remarks) | Sale | 522 | 24.75 | 12,922 |
| 2015-08-17 | Stahl Wilhelm (SVP, Chief Technology Officer) | Sale | 522 | 24.70 | 12,893 |
| 2015-08-17 | Lockey Claire (See Remarks) | Sale | 522 | 24.69 | 12,888 |
| 2015-08-17 | Orwin John A (President & CEO) | Sale | 5,000 | 24.84 | 124,225 |
| 2015-08-17 | Berman Lance (Chief Medical Officer and SVP) | Sale | 710 | 24.77 | 17,585 |
| 2015-08-17 | Ball Kristine M (Chief Financial Officer & SVP) | Sale | 710 | 24.79 | 17,597 |
| 2015-07-31 | Orwin John A (President & CEO) | Sale | 10,000 | 33.83 | 338,250 |
| 2015-07-31 | Orwin John A (President & CEO) | Option Ex | 5,000 | 7.40 | 37,000 |
| 2015-07-30 | Orwin John A (President & CEO) | Sale | 20,000 | 33.84 | 676,840 |
| 2015-07-30 | Orwin John A (President & CEO) | Option Ex | 20,000 | 7.40 | 148,000 |
| 2015-06-11 | Butler John P. | Sale | 1,100 | 34.62 | 38,086 |
| 2015-06-11 | Schuetz Thomas J. | Sale | 1,000 | 34.57 | 34,571 |
| 2015-06-11 | Hastings Paul J | Sale | 1,454 | 34.63 | 50,359 |
| 2015-06-11 | Mcgirr David W J | Sale | 1,220 | 34.67 | 42,299 |
| 2015-06-01 | Orwin John A (President & CEO) | Sale | 13,555 | 36.37 | 492,968 |
| 2015-06-01 | Orwin John A (President & CEO) | Option Ex | 8,555 | 7.40 | 63,307 |
| 2015-05-29 | Orwin John A (President & CEO) | Sale | 20,000 | 36.69 | 733,740 |
| 2015-05-29 | Orwin John A (President & CEO) | Option Ex | 20,000 | 7.40 | 148,000 |
| 2015-05-18 | Isaly Samuel D | Sale | 1,457,551 | 34.13 | 49,746,215 |
| 2015-05-11 | Veitinger Klaus R Dr | Sale | 5,834 | 36.06 | 210,385 |
| 2015-05-11 | Veitinger Klaus R Dr | Option Ex | 5,834 | 3.96 | 23,102 |
| 2015-04-10 | Veitinger Klaus R Dr | Sale | 5,832 | 35.35 | 206,178 |
| 2015-04-10 | Veitinger Klaus R Dr | Option Ex | 5,832 | 3.96 | 23,094 |
| 2015-03-10 | Veitinger Klaus R Dr | Sale | 5,834 | 38.67 | 225,594 |
| 2015-03-10 | Veitinger Klaus R Dr | Option Ex | 5,834 | 4.30 | 25,115 |
| 2015-03-05 | Ball Kristine M (Chief Financial Officer & SVP) | Sale | 3,000 | 41.00 | 123,000 |
| 2015-03-05 | Ball Kristine M (Chief Financial Officer & SVP) | Option Ex | 3,000 | 3.96 | 11,880 |
| 2015-03-04 | Lockey Claire (See Remarks) | Sale | 10,000 | 40.00 | 400,000 |
| 2015-03-04 | Lockey Claire (See Remarks) | Option Ex | 10,000 | 4.22 | 42,200 |
| 2015-03-03 | Ball Kristine M (Chief Financial Officer & SVP) | Sale | 519 | 38.80 | 20,137 |
| 2015-02-27 | Krasnow Ronald A. (See Remarks) | Sale | 348 | 39.00 | 13,572 |
| 2015-02-26 | Krasnow Ronald A. (See Remarks) | Sale | 5,000 | 39.00 | 195,000 |
| 2015-02-25 | Krasnow Ronald A. (See Remarks) | Sale | 5,000 | 39.00 | 195,000 |
| 2015-02-24 | Krasnow Ronald A. (See Remarks) | Sale | 5,000 | 39.00 | 195,000 |
| 2015-02-24 | Berman Lance (Chief Medical Officer and SVP) | Sale | 5,000 | 38.22 | 191,110 |
| 2015-02-24 | Berman Lance (Chief Medical Officer and SVP) | Option Ex | 5,000 | 5.11 | 25,535 |
| 2015-02-23 | Krasnow Ronald A. (See Remarks) | Sale | 5,000 | 39.00 | 195,000 |
| 2015-02-10 | Veitinger Klaus R Dr | Sale | 5,834 | 32.42 | 189,149 |
| 2015-02-10 | Veitinger Klaus R Dr | Option Ex | 5,834 | 4.65 | 27,128 |
| 2015-01-21 | Krasnow Ronald A. (See Remarks) | Sale | 55,000 | 35.00 | 1,925,000 |
| 2015-01-21 | Krasnow Ronald A. (See Remarks) | Option Ex | 55,000 | 3.56 | 195,800 |
| 2015-01-21 | Lockey Claire (See Remarks) | Sale | 5,000 | 35.00 | 175,000 |
| 2015-01-21 | Lockey Claire (See Remarks) | Option Ex | 5,000 | 4.65 | 23,250 |
| 2015-01-21 | Ball Kristine M (Chief Financial Officer & SVP) | Sale | 3,000 | 36.00 | 108,000 |
| 2015-01-21 | Ball Kristine M (Chief Financial Officer & SVP) | Option Ex | 3,000 | 3.96 | 11,880 |
| 2015-01-14 | Krasnow Ronald A. (See Remarks) | Sale | 5,000 | 33.77 | 168,830 |
| 2015-01-14 | Krasnow Ronald A. (See Remarks) | Option Ex | 5,000 | 2.76 | 13,799 |
| 2015-01-12 | Veitinger Klaus R Dr | Sale | 5,834 | 32.48 | 189,499 |
| 2015-01-12 | Veitinger Klaus R Dr | Option Ex | 5,834 | 4.65 | 27,128 |
| 2014-12-12 | Veitinger Klaus R Dr | Sale | 9,852 | 32.50 | 320,190 |
| 2014-12-12 | Veitinger Klaus R Dr | Option Ex | 9,852 | 4.65 | 45,811 |
| 2014-12-11 | Veitinger Klaus R Dr | Sale | 150 | 32.50 | 4,875 |
| 2014-12-11 | Veitinger Klaus R Dr | Option Ex | 150 | 4.65 | 697 |
| 2014-12-10 | Veitinger Klaus R Dr | Sale | 4,167 | 31.37 | 130,710 |
| 2014-12-10 | Veitinger Klaus R Dr | Option Ex | 4,167 | 4.65 | 19,376 |
| 2014-12-09 | Lockey Claire (See Remarks) | Sale | 8,000 | 30.00 | 240,000 |
| 2014-12-09 | Lockey Claire (See Remarks) | Option Ex | 8,000 | 4.65 | 37,200 |
| 2014-12-09 | 5am Co-investors Iii, L.p. | Sale | 589,637 | 30.04 | 17,712,695 |
| 2014-11-28 | Berman Lance (Chief Medical Officer and SVP) | Sale | 5,000 | 25.00 | 125,000 |
| 2014-11-28 | Berman Lance (Chief Medical Officer and SVP) | Option Ex | 5,000 | 5.11 | 25,535 |
| 2014-11-25 | Berman Lance (Chief Medical Officer and SVP) | Sale | 15,000 | 25.00 | 375,000 |
| 2014-11-25 | Berman Lance (Chief Medical Officer and SVP) | Option Ex | 15,000 | 5.11 | 76,605 |
| 2014-11-24 | Berman Lance (Chief Medical Officer and SVP) | Sale | 15,000 | 25.00 | 375,000 |
| 2014-11-24 | Berman Lance (Chief Medical Officer and SVP) | Option Ex | 15,000 | 3.96 | 59,400 |
| 2014-11-20 | Veitinger Klaus R Dr | Sale | 3,334 | 22.50 | 75,015 |
| 2014-11-20 | Veitinger Klaus R Dr | Option Ex | 3,334 | 4.65 | 15,503 |
| 2014-11-10 | Veitinger Klaus R Dr | Sale | 2,500 | 20.06 | 50,145 |
| 2014-11-10 | Veitinger Klaus R Dr | Option Ex | 2,500 | 4.65 | 11,625 |
| 2014-10-10 | Veitinger Klaus R Dr | Sale | 2,500 | 19.59 | 48,970 |
| 2014-10-10 | Veitinger Klaus R Dr | Option Ex | 2,500 | 4.65 | 11,625 |
| 2014-09-24 | Berman Lance (Chief Medical Officer and SVP) | Sale | 5,000 | 22.00 | 110,000 |
| 2014-09-24 | Berman Lance (Chief Medical Officer and SVP) | Option Ex | 5,000 | 5.11 | 25,535 |
| 2014-09-17 | Isaly Samuel D | Sale | 49,000 | 25.07 | 1,228,430 |
| 2014-09-16 | 5am Co-investors Ii Lp | Sale | 612,540 | 26.03 | 15,944,416 |
| 2014-09-16 | Isaly Samuel D | Sale | 45,000 | 25.75 | 1,158,975 |
| 2014-09-10 | Veitinger Klaus R Dr | Sale | 4,167 | 23.00 | 95,849 |
| 2014-09-10 | Veitinger Klaus R Dr | Option Ex | 4,167 | 4.65 | 19,376 |
| 2014-08-29 | Stahl Wilhelm (SVP, Pharmaceutical Operations) | Sale | 15,785 | 25.29 | 399,250 |
| 2014-08-29 | Stahl Wilhelm (SVP, Pharmaceutical Operations) | Option Ex | 15,785 | 4.30 | 67,954 |
| 2014-08-26 | 5am Co-investors Ii Lp | Sale | 96,310 | 26.53 | 2,555,104 |
| 2014-08-25 | Berman Lance (Chief Medical Officer and SVP) | Sale | 5,000 | 26.48 | 132,380 |
| 2014-08-25 | Berman Lance (Chief Medical Officer and SVP) | Option Ex | 5,000 | 7.40 | 37,000 |
| 2014-08-25 | 5am Co-investors Ii Lp | Sale | 336,690 | 26.50 | 8,922,285 |
| 2014-08-22 | Berman Lance (Chief Medical Officer and SVP) | Sale | 15,000 | 25.69 | 385,350 |
| 2014-08-22 | Berman Lance (Chief Medical Officer and SVP) | Option Ex | 15,000 | 5.68 | 85,200 |
| 2014-08-15 | Isaly Samuel D | Sale | 990,000 | 26.35 | 26,086,500 |
| 2014-08-11 | Veitinger Klaus R Dr | Sale | 4,167 | 27.73 | 115,563 |
| 2014-08-11 | Veitinger Klaus R Dr | Option Ex | 4,167 | 4.65 | 19,376 |
| 2014-08-08 | Stahl Wilhelm (SVP, Pharmaceutical Operations) | Sale | 49,300 | 25.09 | 1,237,084 |
| 2014-08-08 | Stahl Wilhelm (SVP, Pharmaceutical Operations) | Option Ex | 49,300 | 3.96 | 195,228 |
| 2014-08-08 | Lockey Claire (See Remarks) | Sale | 10,000 | 26.25 | 262,500 |
| 2014-08-08 | Lockey Claire (See Remarks) | Option Ex | 10,000 | 4.65 | 46,500 |
| 2014-07-24 | Berman Lance (Chief Medical Officer and SVP) | Sale | 15,000 | 24.18 | 362,745 |
| 2014-07-24 | Berman Lance (Chief Medical Officer and SVP) | Option Ex | 15,000 | 3.96 | 59,400 |
| 2014-07-23 | Berman Lance (Chief Medical Officer and SVP) | Sale | 15,000 | 24.45 | 366,780 |
| 2014-07-23 | Berman Lance (Chief Medical Officer and SVP) | Option Ex | 15,000 | 3.96 | 59,400 |
| 2014-07-22 | Berman Lance (Chief Medical Officer and SVP) | Sale | 15,000 | 23.67 | 354,990 |
| 2014-07-22 | Berman Lance (Chief Medical Officer and SVP) | Option Ex | 15,000 | 3.96 | 59,400 |
| 2014-07-10 | Veitinger Klaus R Dr | Sale | 4,167 | 23.12 | 96,353 |
| 2014-07-10 | Veitinger Klaus R Dr | Option Ex | 4,167 | 4.65 | 19,376 |
Insider trading activities including stock purchases, stock sales, and option exercises of RLYP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Relypsa Inc (symbol RLYP, CIK number 1416792) see the Securities and Exchange Commission (SEC) website.